Teva Pharmaceutical Industries Ltd.
Teva Receives Favorable Court Decision Regarding Seasonique(R)
Published in Women's Health Law Weekly, April 18th, 2010
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®. The ANDA sought approval to market a generic version of Seasonique in the U.S. before the patent expires on January 30, 2024.
"We are pleased with the Court's decision finding our patent to be valid and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Bullying
Scientists at University of New Brunswick target bullying - Institute for Alternative Futures
New Report Addresses Potential Benefits and Shortcomings in Development of Risk Evaluation and Mitigation Strategies REMS - Massachusetts General Hospital
Even highly qualified women in academic medicine paid less than equally qualified men - U.S. Department of Justice
Department of Justice Observes April as Sexual Assault Awareness Month - Verizon Wireless
Verizon Wireless Launches Know It Forward in Alabama to Raise the Awareness of Sexual Assault Among College Age Students - Acute Coronary Syndrome
Scientists at University of Bologna publish new data on acute coronary syndrome - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
